Market closed
Biora Therapeutics/$BIOR
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Biora Therapeutics
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.
Ticker
$BIOR
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
58
Website
BIOR Metrics
BasicAdvanced
$9.7M
Market cap
-
P/E ratio
-$35.65
EPS
1.23
Beta
-
Dividend rate
Price and volume
Market cap
$9.7M
Beta
1.23
52-week high
$4.33
52-week low
$2.38
Financial strength
Current ratio
0.2
Quick ratio
0.134
Long term debt to equity
-49.447
Total debt to equity
-54.459
Interest coverage (TTM)
-8.60%
Management effectiveness
Return on assets (TTM)
-125.06%
Return on equity (TTM)
82.60%
Valuation
Price to revenue (TTM)
8.033
Price to book
-0.11
Price to tangible book (TTM)
-0.1
Price to free cash flow (TTM)
-0.142
Growth
Revenue change (TTM)
777.55%
Earnings per share change (TTM)
-35.28%
3-year revenue growth (CAGR)
2.78%
3-year earnings per share growth (CAGR)
-67.83%
BIOR News
AllArticlesVideos
Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update
GlobeNewsWire·1 day ago
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewsWire·2 weeks ago
Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Biora Therapeutics stock?
Biora Therapeutics (BIOR) has a market cap of $9.7M as of November 09, 2024.
What is the P/E ratio for Biora Therapeutics stock?
The price to earnings (P/E) ratio for Biora Therapeutics (BIOR) stock is 0 as of November 09, 2024.
Does Biora Therapeutics stock pay dividends?
No, Biora Therapeutics (BIOR) stock does not pay dividends to its shareholders as of November 09, 2024.
When is the next Biora Therapeutics dividend payment date?
Biora Therapeutics (BIOR) stock does not pay dividends to its shareholders.
What is the beta indicator for Biora Therapeutics?
Biora Therapeutics (BIOR) has a beta rating of 1.23. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.